Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950157-10-001915
Filing Date
2010-10-07
Accepted
2010-10-06 21:50:38
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sc13da.htm SC 13D/A 118340
2 AGREEMENT AND PLAN OF MERGER DATED OCTOBER 6, 2010 ex-1.htm EX-1 1209517
3 FORM OF IRREVOCABLE UNDERTAKING ex-2.htm EX-2 26751
4 PRESS RELEASE DATED OCTOBER 6, 2010 ex-3.htm EX-3 34147
5 johnson_crucell.jpg GRAPHIC 6345
  Complete submission text file 0000950157-10-001915.txt   1399711
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0209
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address CT CORPORATION SYSTEM 111 EIGTH AVE 13TH FL NEW YORK NY 10011
Business Address ARCHIMEDESWEG 4 2333 CN LEIDEN THE NETHERLANDS P8 00000
CRUCELL NV (Subject) CIK: 0001126136 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51066 | Film No.: 101112793
SIC: 8731 Services-Commercial Physical & Biological Research